Experiments were performed in anesthetized dogs to study some effects of propranolol, 
echolamines may act synergistically with digitalis in the production of arrhythmias,5-9 it is possible that electrical discharge releases stored catecholamines, thereby reinducing digitalis toxicity.
Beta-adrenergic blocking agents have been used to terminate digitalis-induced rhythm disturbances10-12 as well as to increase the threshold for the production of postcountershock arrhythmias in the digitalized animal. 13 Many of these agents produce a nonspecific antiarrhythmic effect in addition to their capacity to induce beta-adrenergic blockade.14-17 Separation of their nonspecific from their beta-adrenergic effect is necessary to clarify how much of their efficacy is due to catecholamine antagonism.
Propranolol,'8 its dextro-rotary isomer,15
and a new agent designated as ICI50,172 were used in studies on digitalis-induced sensitivity to electrical shock. The following questions were considered: (1) Does propranolol abolish shock sensitivity? (2) After 2 min. Propronolol o -F s * s 7 + s i 8 i * e j ; i P 6 * * > . 4 Figure 4 Following recovery from ouabain-induced VT the sinus rate is 175. Atrial pacinig is begun at a rate of 190. Propranolol, 0.2 mg/kg, is administered intravenously. Although the dogs that were not paced developed VT within 132 minutes, the dog shows no evidence of arrhythmia at 2 minutes. At 3 minutes the pacemaker is slowed and VT appears. ulation was slowed, VT appeared in each animal ( fig. 4) . This was in contrast to the group of dogs that was not paced, in which six of 10 animals developed VT within 132 minutes after propranolol.
Discussion
There were two stages of digitalis intoxication in the present studies: overt arrhythmia and latent arrhythmia exposed by electrical shock. Beta-blocking doses of propranolol given during VT did not effect the arrhythmia or the post-arrhythmia sensitization to elecCircsulaion, Volume XXXIX, January 1969 trical shock. By increasing the dose of propranolol it was first possible to terminate the arrhythmia without affecting shock sensitivity, and then to abolish both arrhythmia and shock sensitivity. These observations support previous studies'4-16 implicating a nonspecific, dose-related antiarrhythmic effect in the aboltion of digitalis-induced arrhythmias. This same nonspecific effect was apparently responsible for the abolition of arrhythmias produced by electrical shock. Separation of the two actions of propranolol supported this conclusion. This response was noted within 1.5 minutes after intravenous drug administration. In every instance the sinus rate slowed until a faster ventricular focus usurped as pacemaker. The dependence of this phenomenon on a decrease in atrial rate was supported by the observation that atrial pacing abolished the phenomenon. Furthermore, isoproterenol abolished the VT in the three dogs in which it was given, but only after increasing heart rate slightly. When isoproterenol was discontinued, rate slowed and VT reappeared. The experiments of Becker and co-workers5 are interesting in this regard. Of 5 dogs challenged with isoproterenol during incremental digitalization with ouabain, only three developed VT during isoproterenol in infusion. The remaining two developed arrhythmias 132 minutes after isoproterenol was discontinued. Presumably the sinus rate was decelerating at this time.
The ability of vagal stimulation to unmask digitalis-induced ventricular ectopic activity is well known.20 24 However, to our knowledge, the appearance of digitalis toxicity as a side effect of sympathetic antagonism has not been previously described. Although it is impossible to extrapolate from animal experiments to a clinical setting, these studies make it reasonable to ask whether pure betaadrenergic blockade can, by slowing the sinus rate, enhance rather than depress arrhythmias. The question also arises when severe digitalis toxicity is suspected whether it might be safer to use higher-than-usual doses of propranolol to ensure achieving the nonspecific, antiarrhythmic action of this agent.
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